CD36 is a co-receptor for hepatitis C virus E1 protein attachment-Reference-Cited by-同舟云学术

CD36 is a co-receptor for hepatitis C virus E1 protein attachment

Published:2016-02 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Cheng Jun-Jun,Li Jian-Rui,Huang Meng-Hao,Ma Lin-Lin,Wu Zhou-Yi,Jiang Chen-Chen,Li Wen-Jing,Li Yu-Huan,Han Yan-Xing,Li Hu,Chen Jin-Hua,Wang Yan-Xiang,Song Dan-Qing,Peng Zong-Gen,Jiang Jian-Dong

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep21808.pdf

Reference60 articles.

1. Dubuisson, J. & Cosset, F. L. Virology and cell biology of the hepatitis C virus life cycle: an update. J. Hepatol. 61, S3–S13 (2014).

2. Lindenbach, B. D. & Rice, C. M. The ins and outs of hepatitis C virus entry and assembly. Nat. Rev. Microbiol. 11, 688–700 (2013).

3. Lin, L. T. et al. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol. 13, 187 (2013).

4. Albecka, A. et al. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 55, 998–1007 (2012).

5. Zona, L. et al. CD81-receptor associations–impact for hepatitis C virus entry and antiviral therapies. Viruses 6, 875–892 (2014).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review: cellular attachment and entry factors of human tumor-associated viruses;Future Virology;2024-05-01

2. Natural Compounds as Potential Basis for the Prevention and Treatment of Hepatitis C;Antibiot Khimioter = Antibiotics and Chemotherapy;2024-03-27

3. A review: cellular attachment and entry factors of human tumor-associated viruses;Future Virology;2024-03-03

4. The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target;Pediatric Discovery;2023-06

5. Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies;Viruses;2023-05-11